Antibiotics
The global fight against antibiotic-resistant bacteria, often dubbed "superbugs," has reached a critical juncture. Traditional methods of discovering new antimicrobial compounds are notoriously slow, expensive, and frequently yield diminishing returns, leaving humanity vulnerable to increasingly resilient pathogens. In a significant leap forward, researchers at the University of Pennsylvania
AI
The global health community faces an escalating crisis: antibiotic resistance. As 'superbugs' evolve, rendering existing drugs ineffective, the pipeline for new antibiotics has dwindled significantly, threatening to send medicine back to a pre-antibiotic era. In response to this urgent challenge, researchers at the University of Pennsylvania have developed
Antibiotics
In a groundbreaking development that promises to reshape the landscape of pharmaceutical research, scientists at the University of Pennsylvania have engineered a sophisticated predictive Artificial Intelligence (AI) model tailored to accelerate the discovery of novel antibiotics. This innovation arrives at a critical juncture, as the world grapples with the escalating